Florence Mathebula to Humans
This is a "connection" page, showing publications Florence Mathebula has written about Humans.
Connection Strength
0,292
-
South African Parents' and Grandparents' Perspectives on the Acceptability of Implant Delivery of Treatment to Young Children with HIV. AIDS Behav. 2025 Jan; 29(1):13-21.
Score: 0,018
-
Depression Among Pregnant and Breastfeeding Persons Participating in Two Randomized Trials of the Dapivirine Vaginal Ring and Oral Pre-Exposure Prophylaxis (PrEP) in Malawi, South Africa, Uganda, and Zimbabwe. AIDS Behav. 2024 Jul; 28(7):2264-2275.
Score: 0,017
-
Acceptability of the Dapivirine Vaginal Ring and Oral Truvada Among African Users in Late-Stage of Pregnancy. AIDS Behav. 2024 Mar; 28(3):963-973.
Score: 0,017
-
Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda. AIDS Behav. 2023 Dec; 27(12):4114-4123.
Score: 0,017
-
Examining Associations Between Mental Health, IPV Exposure, HIV Risk Behaviors, and PrEP Use in South African Women: An Analysis of Data from the Charisma Study. AIDS Behav. 2023 Jun; 27(6):2030-2040.
Score: 0,016
-
Acceptability of Implants for HIV Treatment in Young Children: Perspectives of Health Care Providers in Johannesburg, South Africa. AIDS Patient Care STDS. 2022 10; 36(10):389-395.
Score: 0,016
-
''Ask the way from those who have walked it before"-Grandmothers' roles in health-related decision making and HIV pre-exposure prophylaxis use among pregnant and breastfeeding women in sub-Saharan Africa. PLoS One. 2022; 17(9):e0271684.
Score: 0,016
-
Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention. AIDS Behav. 2022 Jun; 26(6):1923-1932.
Score: 0,015
-
Evidence for use of a healthy relationships assessment tool in the CHARISMA pilot study. PLoS One. 2021; 16(12):e0261526.
Score: 0,015
-
Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial. AIDS Behav. 2022 May; 26(5):1597-1606.
Score: 0,015
-
Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study. AIDS Behav. 2022 Mar; 26(3):752-763.
Score: 0,015
-
Using Emoji Stickers to Understand End-User Opinions of the Dapivirine Vaginal Ring for HIV Prevention. AIDS Behav. 2021 Dec; 25(12):3955-3966.
Score: 0,014
-
Acceptability and feasibility of the CHARISMA counseling intervention to support women's use of pre-exposure prophylaxis: results of a pilot study. BMC Womens Health. 2021 03 25; 21(1):126.
Score: 0,014
-
Development and initial validation of a simple tool to screen for partner support or opposition to HIV prevention product use. PLoS One. 2020; 15(12):e0242881.
Score: 0,014
-
After their wives have delivered, a lot of men like going out: Perceptions of HIV transmission risk and support for HIV prevention methods during breastfeeding in sub-Saharan Africa. Matern Child Nutr. 2021 04; 17(2):e13120.
Score: 0,014
-
Generating CHARISMA: Development of an Intervention to Help Women Build Agency and Safety in Their Relationships While Using PrEP for HIV Prevention. AIDS Educ Prev. 2019 10; 31(5):433-451.
Score: 0,013
-
The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa. AIDS Care. 2019 06; 31(6):660-666.
Score: 0,012
-
Negotiating the use of female-initiated HIV prevention methods in a context of gender-based violence: the narrative of rape. Cult Health Sex. 2016; 18(6):611-24.
Score: 0,010
-
Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding". AIDS Behav. 2015 May; 19(5):784-93.
Score: 0,009
-
Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg, South Africa. BMC Womens Health. 2014 Jul 28; 14:88.
Score: 0,009
-
Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa. PLoS One. 2014; 9(2):e89118.
Score: 0,009